The Lancet Neurology in conversation with

187 Folgen

1. William Jagust on amyloid β and cognition

   Vom: 16.8.2023
2. Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury

   Vom: 19.7.2023
3. Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases

   Vom: 21.6.2023
4. Andrew Cole on the complexities underlying epilepsy in people with glioblastoma

   Vom: 18.5.2023
5. Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation

   Vom: 13.4.2023
6. Kerstin Hellwig on family planning considerations in MS

   Vom: 15.3.2023
7. Geraldine Dawson on advances in the prediction of autism during infancy

   Vom: 16.2.2023
8. Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke

   Vom: 19.1.2023
9. Beau Ances on amyloid biomarkers in Alzheimer’s

   Vom: 12.12.2022
10. Axel Petzold on the diagnosis and classification of optic neuritis

    Vom: 16.11.2022
11. Maeike Zijlmans on using biomarkers to tailor epilepsy surgery

    Vom: 18.10.2022
12. Jerome Siegel on sleep habits

    Vom: 14.9.2022
13. Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy

    Vom: 10.8.2022
14. Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    Vom: 13.7.2022
15. Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

    Vom: 15.6.2022
16. Mark Hallett on functional neurological disorder

    Vom: 13.5.2022
17. Eva Feldman on advances in understanding ALS

    Vom: 13.4.2022
18. Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

    Vom: 6.4.2022
19. John Collinge on a treatment for CJD

    Vom: 16.3.2022
20. Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2

    Vom: 22.2.2022